Solutions We Provide
ILC-Header-Logo

Antibody Drug Conjugate (ADC) Manufacturing - Embrace the Future: It’s Happening Now.

ADCs are an advanced cancer therapy designed to precisely target and deliver cytotoxic agents directly to cancer cells.

ILC Dover is the global leader in high-containment systems for handling potent pharmaceutical ingredients. Since 1997, we’ve pioneered single-use isolator technology that lowers capital and operating costs while delivering proven containment performance. Designed for highly potent APIs, including the most powerful toxin linkers, our systems consistently achieve below 1.0 nanogram / m3 airborne concentration containment limit, verified through ISPE SMEPAC testing and SafeBridge Consultants analysis. With no cleaning or filter changes required, the fully disposable design allows safe disposal and faster changeover, getting production running again in hours, not days.

ILC Dover has developed technology for containment across the ADC workflow. The innovative designs protect operators and the environment, leveraging single-use systems that reduce risks of contamination and costs associated with cleaning stainless steel components. This improves production efficiency to when cleaning is eliminated, and the equipment is available quickly.

Let ILC Dover be your trusted partner in ADC Manufacturing —where quality, flexibility, and innovation come together.

Solutions for Every Step of Your ADC Workflow

Challenges in ADC Manufacturing – how ILC Dover solutions improve your process

The customer problem is payload handling and containment. That needs to be stated first and then technology can be discussed.

Across the workflow for manufacturing antibody drug conjugates, there are many challenges that require unique solutions. From solubilizing the toxin linker to chromatography and lyophilization, ILC Dover provides cost effective single use technology. We have proven solutions that do more than provide containment to protect operators and the environment:

  • Streamline production by eliminating cleaning and boosts efficiency and capacity
  • Single use technology like flexible film isolators have easy-to-add options to overcome site specific challenges. Improvements and changes are easily adapted after the installation with no lost production time
  • Containment systems that protect operators, facilities, and the product from contamination to the nanogram level. Test results are validated by 3rd party hygienists.

Explore Our Portfolio

Discover how flexible isolator technology enhances your process

Why Choose ILC Dover for your ADC Workflow

The isolator system is offered in a standard configuration with some options. The standard configuration delivery time is the shortest since it is pre-engineered. Custom designs including the isolator size (WxLxD) and certain features can be added to meet specific process needs.

Downloads & Resources

The Future of ADC Manufacturing White Paper

ILC Dover ADC Workflow Solutions

soloPURE Aseptic Processing Isolator

Sentinel Clear XT™ PAPR System

Sentinel XT™

EZ BioPac Single-Use Powder Transfer System

See for youself how our solutions for Pharmaceutical and Biopharmaceutical Manufacturing can improve your process

ILC Product Photo Employee Group No Background v2